Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
INSTITUTE OF NEURODIVERSITY, NEUROPOWER WORLD, AND SINGAPORE BRINGS NEURODESIGN TO THE FOREFRONT OF SINGAPORE'S URBAN PLANNING 2025-11-18 09:00
Ajinomoto Bio-Pharma Services Wins "Best ADC Preclinical Publication 2024" Award for AJICAP® Technology at 2025 World ADC Awards 2025-11-17 22:26
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US 2025-11-17 22:06
AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment 2025-11-17 13:45
Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine 2025-11-14 17:43
Amorepacific Named CES Innovation Award Honoree for Advanced Electronic Skin Platform 2025-11-14 09:00
Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal 2025-11-14 09:00
KHB Showcases the Enhanced FOCUS PEGASUS MF200 -- Redefining Efficiency in Veterinary Diagnostics 2025-11-13 15:18
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A 2025-11-12 16:12
/C O R R E C T I O N -- Heng Ren Partners/ 2025-11-12 12:31
Alpha IVF Singapore uses Advanced Fertility Genomic Screening and Artificial Intelligence Embryo Scoring to help couples become parents 2025-11-12 10:00
OPALESCENCE Trial Published in EJNMMI: Confirms Theranostic Potential of TLX250-CDx in Breast Cancer 2025-11-12 04:00
Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments 2025-11-12 03:11
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine 2025-11-11 21:01
Guo Guangchang: Fosun Strengthens Globalization Capabilities, Accelerates Innovation through Open Cooperation 2025-11-11 15:41
Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B 2025-11-10 21:30
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting 2025-11-10 21:15
Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions 2025-11-10 12:00
Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress 2025-11-10 10:01
ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milestone in Medical-Grade TPU Materials 2025-11-10 08:45
1 2 3 4 5 6 265